ArticleMathematical biosciences2026
A multiobjective optimization approach to data assimilation for complex biological systems with sparse data.
Article in Mathematical biosciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Loss function influence on hyperparameter optimization for observational healthcare prediction models.Journal of the American Medical Informatics Association : JAMIA · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
This article develops a novel multiobjective data assimilation methodology, addressing challenges that are common in real-world settings, such as severe sparsity of observations, lack of reliable models, and non-stationarity of the system dynamics. These challenges often cause issues and can confound model parameter estimation and initialization that can lead to estimated models with unrealistic qualitative dynamics and induce qualitative and quantitative parameter estimation errors. The proposed multiobjective function is constructed as a sum of components, each serving a different purpose: enforcing point-wise and distribution-wise agreement between data and model output, enforcing agreement of variables and parameters with a model provided, and penalizing unrealistic rapid parameter changes, unless they are due to external drivers or interventions. This methodology was motivated by, developed and evaluated in the context of estimating blood glucose levels in different medical settings. Both simulated and real data are used to evaluate the methodology from different perspectives, such as its ability to estimate unmeasured variables, its ability to reproduce the correct qualitative blood glucose dynamics, how it manages non-stationarity, and how it performs when given a range of dense and severely sparse data. The results show that a multicomponent cost function can balance the minimization of point-wise errors with global properties, robustly preserving correct qualitative dynamics and managing data sparsity.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.